The dense expression of endoglin on blood vessels in highly vascularized tumors led to the study of TRC105 in glioblastoma [59], renal cell carcinoma (RCC) [60], hepatocellular carcinoma [61] and breast cancer [62]. This evidence concerns the gene ENG and breast carcinoma.